Events

Dynamic Global Events’ KOL & Thought Leader Engagement Summit April 28th -29th, 2021 

Industry professionals are invited to attend the KOL & Thought Leader Engagement Summit, hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

The event timings on the first day are 8:30 am – 5:00 pm. The next day’s timings are 8:30 am – 4:15 pm, concluding the event with a discussion on the understanding of KOL Motivators and Expectations.

DGE’s two-day event will include presentations, and discussions from leading life science professionals on how to identify, engage, build, and nuture relationships with KOLs. The KOL & Thought Leadership Engagement Summit offers this unique opportunity to learn about regulations and identify the best strategies to stay in compliance when engaging with KOLs.

The key theme of the Engagement Summit revolves around the acquisition of medical and scientific information, along with transparent, compliant compensation for advisory board participation, in an environment where industry professionals are engaging traditional KOLs as well as new thought leaders.

The introductory speech will be given by Bryan N. Bischel, Ph.D. Medical Director, Hepatology at Mallinckrodt Pharmaceuticals, USA. Bryan is an accomplished senior medical affairs professional with more than 15 years of progressively responsible medical affairs experience. He is a strategic thinker and a results-driven leader with high emotional intelligence and skills to hire, train, and direct high-impact MSL teams.

Additional influential and respected speakers include:

  • Jefferson Tea, VP, Medical and Scientific Affairs, TAKEDA Canada
  • Alice Chung, Senior Manager, Strategic Analytics and Intelligence, Medical and Scientific Team, Genentech
  • Christina Tankersley, Senior Director, MSLs, Sanofi Pasteur
  • Alan Polnariev, Senior MSL, Nephrology, AstraZeneca
  • Kevin Ryan, VP, Chief Compliance Offer, Acadia

KOL and Thought Leader Engagement professionals can leverage the event to:

  • Gain knowledge from top experts on how to effectively engage with KOLs
  • Identify best strategies to establish and maintain meaningful relationships with KOLs
  • Learn about legal regulations and how to stay in compliance when engaging with KOLs
  • Learn about different approaches and methodologies for identifying KOLs
  • Examine the different platforms used to identify, track, and map KOLs

In these uncertain times of public fear and distrust, DGE’s premier KOL & Thought Leader Engagement Summit will help bridge between regulations, demand for new products, and cultivating KOL relationships that offer credibility to the products of the medical community.

To register for this event, please visit https://ibn.fm/IT1sy

To receive a discount on your registration, please use code IBN2021.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients

While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…

1 day ago

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…

2 days ago

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 

The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…

2 days ago

As Cases of Measles Rise, US Officials Double Down on Contact Tracing and Vaccination

As July came to an end, the United States reached an undesirable milestone: exceeding the…

3 days ago

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…

1 week ago

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months…

1 week ago